---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-134882"
form_type: "8-K"
ticker: "STOK"
cik: "0001623526"
company_name: "Stoke Therapeutics, Inc."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-19T23:57:15.158930+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Stoke Therapeutics shareholders elect three Class III directors at 2025 annual meeting

## Summary
- Edward M. Kaye, Seth L. Harrison, and Arthur O. Tzianabos elected as Class III directors with ~29.2M votes each.
- Ratification of KPMG as independent auditor for FY2025 approved with 38.7M for vs 67.8K against.
- Non-binding advisory vote on named executive officer compensation approved with 30.5M for vs 2.9M against.
- Advisory vote on frequency of future say-on-pay set at one year (33.1M votes) as preferred frequency.

## SEC filing metadata
- accession: 0001193125-25-134882
- form_type: 8-K
- ticker: STOK
- cik: 0001623526
- company_name: Stoke Therapeutics, Inc.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1623526/000119312525134882/0001193125-25-134882-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1623526/000119312525134882/d936696d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-134882
- JSON: https://secwatch.observer/filing/0001193125-25-134882.json
- Plain text: https://secwatch.observer/filing/0001193125-25-134882.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.